Mammary Paget Disease is a rare type of cancer that affects the skin of the breast, often around the nipple. It can look like a rash or eczema, but it's a form of cancer.
Every report comes from a Lived member, sent anonymously.
Have you had Mastectomy for Mammary Paget Disease?
Mammary Paget disease, usually called Paget disease of the breast, is a rare form of breast cancer that shows up in the skin of the nipple and usually the areola (the darker circle of skin around the nipple). It accounts for about 1% to 3% of breast cancers. Its early signs look like an ordinary skin problem: itching, tingling or redness of the nipple, and skin that is flaky, crusted or thickened. The nipple may flatten, and there may be yellowish or bloody discharge. Because these changes resemble eczema or dermatitis, Paget disease is easy to overlook. What makes it important is what usually lies beneath it: it is almost always linked to a cancer inside the same breast, either an early, contained form or an invasive one. Some people also notice a lump. It is more common in women after menopause, but it can also affect men. It is unrelated to Paget disease of bone, which only shares the name.
The cause is not fully understood. In many people, cancer cells from a tumor inside the breast appear to travel through the milk ducts to the skin of the nipple. In others, the cancer may begin in the nipple itself. The risk factors are the same as for breast cancer in general, including older age, a personal or family history of breast cancer, and inherited gene changes such as BRCA1 and BRCA2. Having a risk factor does not mean someone caused their cancer or will necessarily develop it. Paget disease is not an infection and cannot be passed to another person.
A persistent nipple rash cannot be diagnosed by its appearance alone, so the key test is a skin biopsy: a small sample of the nipple or areola skin is examined under a microscope for the cancer cells that define Paget disease (Paget cells). Depending on the area, the sample may be scraped from the surface, shaved off, or removed with a small circular or wedge-shaped cut. Because the skin change is usually a sign of a tumor deeper in the breast, a clinical breast exam and imaging come next. A mammogram, breast ultrasound or breast MRI looks for any abnormal area inside the breast, and any area found is biopsied too. If cancer is present, the cells are tested for hormone receptors and a protein called HER2, results that shape which treatments will work. Scans such as CT or PET may be used to check whether cancer has spread. If the skin biopsy shows Paget disease and imaging finds nothing inside the breast, it is usually treated as stage 0 breast cancer, or ductal carcinoma in situ (DCIS), meaning abnormal cells that have not invaded surrounding tissue. Even then, some people turn out to have invasive cancer when the removed tissue is examined, which is why the final stage is set after surgery.
Treatment follows whatever cancer lies beneath the nipple changes. Surgery is the main step, and it removes the nipple and areola along with any underlying tumor. When Paget disease comes with DCIS or no tumor inside the breast, treatment resembles DCIS treatment, with more extensive surgery to the nipple to remove the Paget cells. One option is breast-conserving surgery, which keeps most of the breast and is usually followed by radiation therapy to lower the chance of the cancer returning. The other is mastectomy, removal of the whole breast, which may be followed by breast reconstruction if desired. Studies pooling real-world data suggest that breast-conserving surgery without radiation is not a good choice when an underlying cancer is present. When there is invasive breast cancer, Paget disease is treated as that cancer, according to its stage and biomarker results. Surgeons often check nearby lymph nodes in the armpit with a sentinel lymph node biopsy, which removes the first few nodes the cancer would drain to. Additional treatment may include radiation, hormone-blocking therapy for hormone receptor-positive cancer, HER2-targeted drugs for HER2-positive cancer, or chemotherapy. The choice weighs how far the cancer has spread, its biology, and personal preferences about keeping the breast.
The outlook depends mostly on whether a tumor is present inside the breast and whether it is contained (DCIS) or invasive, and if invasive, on its stage. Paget disease found with DCIS alone generally has a better outlook than Paget disease with invasive cancer, a lump that can be felt, or cancer in the lymph nodes. Overall, Paget disease tends to have a slightly less favorable outlook than other breast cancers, and your care team is best placed to explain what your own results mean. Losing the nipple and areola changes how the breast looks and feels, even when most of the breast is kept. After healing, a nipple and areola can be re-created surgically or with tattooing if desired. Hormone therapy for receptor-positive cancer is usually taken for 5 years or more, so treatment can continue long after surgery. After treatment, follow-up involves regular checkups and mammograms of any remaining breast tissue to watch for the cancer returning.
Arrange a medical evaluation for any nipple or areola skin change that does not clear up, keeps returning, or comes with nipple flattening, discharge or a breast lump. Ask about a biopsy if a nipple rash has been treated as eczema and has not resolved. After treatment, tell your care team promptly about new skin changes, a lump, or swelling in the breast, chest wall or armpit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Mammary Paget Disease is like, what's helped you, or ask the community a question.